ARBUTUS BIOPHARMA CORP's ticker is ABUS and the CUSIP is 03879J100. A total of 55 filers reported holding ARBUTUS BIOPHARMA CORP in Q3 2015. The put-call ratio across all filers is 0.67 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $95,251 | +30.0% | 31,436 | 0.0% | 0.00% | – |
| Q4 2022 | $73,246 | +22.1% | 31,436 | -0.4% | 0.00% | – |
| Q3 2022 | $60,000 | -29.4% | 31,551 | +0.3% | 0.00% | – |
| Q2 2022 | $85,000 | -38.0% | 31,467 | -31.4% | 0.00% | – |
| Q1 2022 | $137,000 | -97.6% | 45,900 | -96.4% | 0.00% | -100.0% |
| Q4 2015 | $5,730,000 | -54.2% | 1,287,560 | -37.4% | 0.00% | -50.0% |
| Q3 2015 | $12,523,000 | – | 2,056,300 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Whitefort Capital Management, LP | 11,895,477 | $24,147,818 | 12.66% |
| Two Seas Capital LP | 8,280,818 | $16,810,061 | 3.38% |
| FourWorld Capital Management LLC | 1,341,907 | $2,724,071 | 0.51% |
| Tejara Capital Ltd | 180,077 | $365,556 | 0.21% |
| Woodline Partners LP | 4,719,903 | $9,581,403 | 0.11% |
| Hudson Bay Capital Management LP | 8,299,808 | $16,848,610 | 0.07% |
| Kepos Capital LP | 155,691 | $316 | 0.06% |
| Virtus ETF Advisers LLC | 40,040 | $81,281 | 0.05% |
| Centiva Capital, LP | 1,071,705 | $2,175,561 | 0.05% |
| Kades & Cheifetz LLC | 20,000 | $40,600 | 0.03% |